Top Markets
#1 Black Phoenix Black Phoenix +355.13%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +68.86%
#4 OpenEden OpenEden +60.23%
#5 Akedo Akedo +56.95%
#6 BasedHype BasedHype +26.68%
#7 Cryptopia Cryptopia +21.54%
#8 Avantis Avantis +19.51%
#9 Humanity Humanity +19.18%
#10 Ether.fi Ether.fi +17.32%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
Classement en actions #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.
Prix de l'action
$0.00162013
Dernière synchronisation: 2025-01-03
Capitalisation boursière
$156.25K
Changement (1 jour)
0.36%
Changement (1 an)
0.00%
Pays
SE
Échange Cyxone AB (publ) (CYXO)

Catégorie

Healthcare
Ratio P/B pour Cyxone AB (publ) (CYXO)
Ratio P/B au August 2026 TTM : 0.05
Selon les derniers rapports financiers et le cours de l'action de Cyxone AB (publ), le ratio cours/valeur comptable actuel (TTM) est 0.05. À la fin de 2022, le ratio P/B était de 0.95.
Historique du ratio P/B pour Cyxone AB (publ) de 2015 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
2026 (TTM) 0.05 -80.68%
2023 0.25 -73.81%
2022 0.95 -62.04%
2021 2.50 -27.47%
2020 3.45 49.69%
2019 2.31 74.16%
2018 1.32 -75.84%
2017 5.48 22.16%
2016 4.49 -98.16%
2015 243.41 0.00%
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 12,863.35%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 13,043.48%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 7,423.81%
BE